I believe it would be instructive to shareholders if Missling were to clarify what the METHODOLOGICAL issues were. Nothing proprietary in that info. Perhaps they even beat the EMA/CHMP minutes which may be forthcoming. GIGO is hard to overcome if that was the issue EMA had. I have forever here NOT been a fan of over manipulation of the raw data.
As I have liquidated for the present (perhaps through next dilution) I can only paper speculate the returns in the future.
Market Data 
Markets 
AI
